Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical Pathway

Choice of direct acting antiviral (DAA) therapy for Hepatitis C Virus (HCV) in the United Kingdom and similar settings usually requires knowledge of the genotype and, in some cases, antiviral resistance (AVR) profile of the infecting virus. To determine these, most laboratories currently use Sanger...

Descripción completa

Detalles Bibliográficos
Autores principales: Manso, Carmen F., Bibby, David F., Lythgow, Kieren, Mohamed, Hodan, Myers, Richard, Williams, David, Piorkowska, Renata, Chan, Yuen T., Bowden, Rory, Ansari, M. Azim, Ip, Camilla L. C., Barnes, Eleanor, Bradshaw, Daniel, Mbisa, Jean L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583327/
https://www.ncbi.nlm.nih.gov/pubmed/33162957
http://dx.doi.org/10.3389/fmicb.2020.576572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583327/
https://www.ncbi.nlm.nih.gov/pubmed/33162957
http://dx.doi.org/10.3389/fmicb.2020.576572

Ejemplares similares